Division News

Dr. Lori Orlando leads the team behind MeTree and studies decision modeling and implementation science as it relates to identifying and managing individuals in clinical settings at increased risk for medical conditions.

The February 8, 2022, session of Duke Medicine LEADS featured Bryan C. Batch, MD, MHS, Nia S. Mitchell, MD, MPH, Julius Wilder, MD presenting on "Perspectives on Health Disparities Research." 

Pearls

More effective and equitable implementation of cancer screening represents a significant opportunity for the National Cancer Program, with the potential to reduce the burden of cancer, according to a report released February 2, 2022, by the President’s Cancer Panel. The Panel’s report, Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access, presents goals and recommendations to optimize cancer screening informed by a series of meetings conducted 2020-2021.

Fatima Syed, MD, has been selected to serve as the new Director of the Primary Care Leadership Track (PCLT) at the School of Medicine. 

The January 25, 2022, session of Duke Medicine LEADS featured Amit Patel, MD, Caroline Sloan, MD, Gabriela M. Maradiaga Panayotti, MD, and Daniella Zipkin, MD presenting "Patient Advocacy and Involvement in Governmental Affairs." 

Pearls

Katherine Neal, MD, is an Assistant Professor of Medicine in the General Internal Medicine (GIM) division and a hospitalist at Duke University Hospital. Learn more in our interview! 

Post submitted by Fatima Syed, MD, a primary care physician and a Vice Chief for Diversity, Equity, and Inclusion for the General Internal Medicine division, along with Dr. Sonya Patel-Nguyen.

I’m the child of Pakistani Muslim immigrants. 

My dad spent much of his early years in the US in rural North Carolina. This was 1970 America, and my dad spent his early years learning American history and reading the speeches of Dr. King. 

Dr. L. Ebony Boulware is the first-author on a perspective in New England Journal of Medicine (NEJM) published today entitled, Combating Structural Inequities — Diversity, Equity, and Inclusion in Clinical and Translational Research. 

Delani Mann-Johnson, MD, Omobonike Oloruntoba-Sanders, MD, and Matthew Sinclair, MD, have been selected in the 2022 class of ADVANCE-UP Scholars.

The Duke Center for Applied Genomics & Precision Medicine’s Associate Director, Christopher W. Woods, MD, co-authored a recent publication in the BMC Public Health Journal studying the impact of rapid at-home testing on COVID-19 trends, “At-home testing to mitigate community transmission of SARS-CoV-2: protocol for public health intervention with a nested prospective cohort study.” This non-pharmaceutical intervention remains critical to controlling disease transmission and can ease the burden associated with facility-based testing. At-home testing can additionally improve testing access in high-risk communities. This study evaluates the impact that at-home testing has on both COVID-19 transmissions and socio-behavioral patterns in underserved populations.